Market Overview

Scott+Scott Attorneys at Law LLP Reminds Investors of its Investigation into Menlo Therapeutics Inc. (MNLO)

Share:

Scott+Scott
Attorneys at Law LLP
("Scott+Scott"), a national shareholder and
consumer rights litigation firm, is investigating whether Menlo
Therapeutics Inc. ("Menlo" or the "Company") (NASDAQ:MNLO) or certain
of its officers and directors violated federal securities laws. If you
purchased Menlo stock in or after the Company's January 2018 initial
public offering ("IPO"), you are encouraged to contact a Scott+Scott
attorney at (844) 818-6982 for more information.

Menlo is a late-stage biopharmaceutical company focused on the
development of serlopitant for the treatment of pruritus associated with
various underlying dermatologic conditions and for refractory chronic
cough.

This investigation concerns whether Menlo's filings with the U.S.
Securities and Exchange Commission in connection with the IPO contained
untrue statements of material fact or omitted material information,
specifically regarding the Company's second Phase 2 clinical trial of
patients treated with serlopitant.

On April 9, 2018, Menlo disclosed that Phase 2 clinical trial of
serlopitant for the treatment of pruritus in adults and adolescents with
a history of atopic dermatitis failed to meet its primary or key
secondary efficacy endpoints. The trial showed no statistically
significant difference between patients treated with serlopitant and
patients treated with placebo.

On this news, the price of Menlo stock closed at $8.17 on April 9, 2018,
a 76.8% decline from its previous close price of $35.22, and a 51%
decline from the IPO price of $17.00.

What You Can Do

If you purchased Menlo common stock, and you wish to discuss this
investigation, please contact attorney Joe Pettigrew at (844) 818-6982,
or at jpettigrew@scott-scott.com,
or visit the Menlo investigation page on our website at https://scott-scott.com/investigation/menlo/.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities,
antitrust, and employee retirement plan actions throughout the United
States. The firm represents pension funds, foundations, individuals, and
other entities worldwide with offices in New York, London, Connecticut,
California, and Ohio.

Attorney Advertising

View Comments and Join the Discussion!